Importantly, they found that the hypermethylation of p16, p53, and p21 genes was able to downregulate their mRNA expression and activate proto-oncogenes, which could lead to genomic alterations, downstream function dysregulation, and cancer development risk. The gene discussed is TP53; the disease is cancer.